Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Surgical Technique Helps Treat Pseudogynecomastia

By HospiMedica International staff writers
Posted on 02 Jul 2020
A novel excisional approach helps male patients with pseudogynecomastia following massive weight loss (MWL), according to a new study. More...


Developed by researchers at the University of Texas (UT) Southwestern Medical Centre (Dallas, TX, USA) and in private practice, the technique involves a modified elliptical excision and nipple-areola complex (NAC) transposition on a thinned inferior dermal pedicle, in addition to liposuction, as an alternative to conventional mastopexy body contouring procedures for treating male chest deformity after MWL, which often leads to suboptimal results. The researchers reported the results of a retrospective chart review in 14 male patients, who were followed for an average of 8.1 months.

The patients were characterized by age, method of weight loss, pre-weight loss body mass index (BMI), post-weight loss BMI, total weight loss, grade of pseudogynecomastia, and concurrent procedures. The average weight lost was 79.72 kg, with pre-weight loss BMI averaging 52.0 kg/m2 and post-weight loss BMI 29.6 kg/m2. The average amount of tissue removed was 2,615 grams. In all, 28.6% of the patients experienced minor complications, including asymmetry, delayed wound healing, hyperpigmentation, and seroma. There were no wound infections, hematomas, flap necrosis, or dysesthesia. The study was published on June 16, 2020, in Aesthetic Surgery Journal: Open Forum.

“Due to several cosmetic advantages and low complication profile, our technique is an attractive option for treating male chest deformity after MWL,” concluded senior author Professor Jeffrey Kenkel, MD, of UT Southwestern Medical Center, and colleagues. “This is a nice alternative to the standard nipple grafting techniques we have used for years. It allows us to preserve the shape of the nipple and in many cases the color in patients of color.”

Pseudogynecomastia is defined by retained retroareolar fat without glandular hypertrophy, often with excess tissue and skin anteriorly and laterally; this in contrast to gynecomastia, which is often idiopathic and results in proliferation of glandular tissue. Treatment for pseudogynecomastia generally requires excision of excess tissue and skin for all but the mildest forms.

Related Links:
University of Texas Southwestern Medical Centre


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.